Endo International plc: Endo Aesthetics to Introduce New Clinical Study of Qwo (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting
DUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo (collagenase clostridium histolyticum-aaes)
Jamesp Tursi Dermatol Clin Joely Kaufman Janette Prnewswire Endo International Exchange Commission Endo International
Source: finanznachrichten.de